Investor Relations
Lipocine is a biopharmaceutical company leveraging its proprietary technology platform to develop innovative products with effective oral delivery.
Lipocine to Host Virtual KOL Event on LPCN 2401 for Improved Body Composition in Obesity Management
2.8 MB
Wednesday, October 16, 2024
11:00am EDT
Innovating beyond boundaries for patients
Krista Fogarty phone: (801) 994-7383 email: kf@lipocine.com